Literature DB >> 27319344

Intracellular recycling and cross-presentation by MHC class I molecules.

Peter van Endert1,2,3.   

Abstract

Cross-presentation of internalized antigens by dendritic cells requires efficient delivery of Major Histocompatibility Complex (MHC) class I molecules to peptide-loading compartments. Strong evidence suggests that such loading can occur outside of the endoplasmic reticulum; however, the trafficking pathways and sources of class I molecules involved are poorly understood. Examination of non-professional, non-phagocytic cells has revealed a clathrin-independent, Arf6-dependent recycling pathway likely traveled by internalized optimally loaded (closed) class I molecules. Some closed and all open MHC class I molecules travel to late endosomes to be degraded but might also partly be re-loaded with peptides and recycled. Studies of viral interference revealed pathways in which class I molecules are directed to degradation in lysosomes upon ubiquitination at the surface, or upon AP-1 and HIV-nef-dependent misrouting from the Golgi network to lysosomes. While many observations made in non-professional cells remain to be re-examined in dendritic cells, available evidence suggests that both recycling and neo-synthesized class I molecules can be loaded with cross-presented peptides. Recycling molecules can be recruited to phagosomes triggered by innate signals such as TLR4 ligands, and may therefore specialize in loading with phagocytosed antigens. In contrast, AP-1-dependent accumulation at, or trafficking through, a Golgi compartment of newly synthesized molecules appears to be important for cross-presentation of soluble proteins and possibly of long peptides that are processed in the so-called vacuolar pathway. However, significant cell biological work will be required to confirm this or any other model and to integrate knowledge on MHC class I biochemistry and trafficking in models of CD8(+) T-cell priming by dendritic cells.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MHC class I; cross-presentation; endosome

Mesh:

Substances:

Year:  2016        PMID: 27319344     DOI: 10.1111/imr.12424

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  22 in total

1.  TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.

Authors:  Devin B Lowe; Camille K Bivens; Alexis S Mobley; Christian E Herrera; Amanda L McCormick; Timea Wichner; Manoj K Sabnani; Laurence M Wood; Jon A Weidanz
Journal:  MAbs       Date:  2017 May/Jun       Impact factor: 5.857

2.  Peptidoglycan Metabolite Photoaffinity Reporters Reveal Direct Binding to Intracellular Pattern Recognition Receptors and Arf GTPases.

Authors:  Yen-Chih Wang; Nathan P Westcott; Matthew E Griffin; Howard C Hang
Journal:  ACS Chem Biol       Date:  2019-02-20       Impact factor: 5.100

3.  Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses.

Authors: 
Journal:  Sci Immunol       Date:  2017-08-25

4.  Differential requirement of Rab22a for the recruitment of ER-derived proteins to phagosomes and endosomes in dendritic cells.

Authors:  Cristina Croce; Luis S Mayorga; Ignacio Cebrian
Journal:  Small GTPases       Date:  2018-01-24

5.  The GTPase Rab39a promotes phagosome maturation into MHC-I antigen-presenting compartments.

Authors:  Freidrich M Cruz; Jeff D Colbert; Kenneth L Rock
Journal:  EMBO J       Date:  2019-12-10       Impact factor: 11.598

Review 6.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

7.  Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells.

Authors:  Geoffrey L Rogers; Jamie L Shirley; Irene Zolotukhin; Sandeep R P Kumar; Alexandra Sherman; George Q Perrin; Brad E Hoffman; Arun Srivastava; Etiena Basner-Tschakarjan; Mark A Wallet; Cox Terhorst; Moanaro Biswas; Roland W Herzog
Journal:  Blood       Date:  2017-05-03       Impact factor: 22.113

8.  MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.

Authors:  Yuanzhang Fang; Lifei Wang; Changlin Wan; Yifan Sun; Kevin Van der Jeught; Zhuolong Zhou; Tianhan Dong; Ka Man So; Tao Yu; Yujing Li; Haniyeh Eyvani; Austyn B Colter; Edward Dong; Sha Cao; Jin Wang; Bryan P Schneider; George E Sandusky; Yunlong Liu; Chi Zhang; Xiongbin Lu; Xinna Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 9.  Cross-presentation of exogenous antigens on MHC I molecules.

Authors:  Jeff D Colbert; Freidrich M Cruz; Kenneth L Rock
Journal:  Curr Opin Immunol       Date:  2020-01-09       Impact factor: 7.486

10.  Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.

Authors:  Gitte Holmen Olofsson; Manja Idorn; Ana Micaela Carnaz Simões; Pia Aehnlich; Signe Koggersbøl Skadborg; Elfriede Noessner; Reno Debets; Bernhard Moser; Özcan Met; Per Thor Straten
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.